Sandbox Financial Partners, LLC Eli Lilly & CO Transaction History

Sandbox Financial Partners, LLC

$276 Million
Q3 2024

A detailed history of Sandbox Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sandbox Financial Partners, LLC holds 4,826 shares of LLY stock, worth $3.78 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

4,826

Previous 4,657 3.63%

Holding current value

$3.78 Million

Previous $4.22 Million 1.4%

% of portfolio

1.55%

Previous 1.64%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$772.14 - $960.02 $130,491 - $162,243	169 Added 3.63%	4,826 $4.28 Million
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $891,590 - $1.12 Million	1,230 Added 35.89%	4,657 $4.22 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $718,338 - $961,035	1,213 Added 54.79%	3,427 $2.67 Million
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $358,179 - $422,246	682 Added 44.52%	2,214 $1.29 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $216,045 - $297,852	497 Added 48.02%	1,532 $822,000
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $107,326 - $143,507	-306 Reduced 22.82%	1,035 $485,000
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $120,524 - $141,550	388 Added 40.71%	1,341 $460,000
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $68,490 - $79,804	213 Added 28.78%	953 $0
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $3,261 - $3,716	-11 Reduced 1.46%	740 $239,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $5,295 - $6,218	-19 Reduced 2.47%	751 $243,000
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $938 - $1,166	4 Added 0.52%	770 $220,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $172,235 - $213,744	766 New	766 $211,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandbox Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandbox Financial Partners, LLC with notifications on news.

Account

Sandbox Financial Partners, LLC Eli Lilly & CO Transaction History